BUREAU VERITAS CERTIFICATION Publishes the World’s First Personal Data Protection Standard
Bureau Veritas Certification has released a technical standard and certification to support companies in their digital transformation and promote confidence in big data.
The new certification from Bureau Veritas Certification is based on the world's first technical standard focused on the management of personal data protection by companies. This standard was prepared by Bureau Veritas Certification, in collaboration with Lexing®, an international network of lawyers specialized in personal data protection.
The purpose is to offer companies an established, independent and credible certification pertaining to the management of the personal data they collect. Certified companies will be able to demonstrate that they manage the personal data they collect in accordance with regulatory requirements and the expectations of their stakeholders.
The new certification anticipates the General Data Protection Regulation (GDPR), which is due to come into force in May 2018 across all 28 European Union member states. The Regulation applies to companies based anywhere in the world that process or hold the personal data of EU citizens.
Furthermore, 80-90% of citizens have expressed concern regarding the protection of their personal data. Data breaches, global cyberattacks and leaks of classified information have now become regular occurrences. This climate of distrust has tended to intensify with big data, even as the General Data Protection Regulation will require organizations that process data to comply with much higher standards.
"Digital responsibility has emerged as one of the major challenges facing companies in coming years. Our framework integrates standards for managing the protection of personal data, such as obtaining consent, proportionality and retention periods, without fundamentally changing a company’s processes or structure", said Sébastien Fox, Vice President Certification Service Line, Bureau Veritas Group.
Companies need to take the lead and anticipate digital transformation by going beyond mere compliance with regulations. Responsible data management will give certified companies an additional way to protect and differentiate their brands, while restoring the trust of consumers, customers, patients and other stakeholders.
"All these steps will only be reassuring if they are clear, and if the assurances given about the protection of individuals’ fundamental rights and freedoms are credible. On this point, only an independent third party can legitimately affirm that ethical rules have been respected. As a global leader in certification, Bureau Veritas Certification is now working with companies in all sectors who want to engage in a rigorous and transparent manner," said Philippe Jeanmart, Senior Vice President Technical, Quality & Risk, Bureau Veritas.
According to Alain Bensoussan, Lexing’s Founder and President, "at a time when this Regulation marks a major turning point in the regulation of personal data, we are pleased and proud to have developed a technical standard to integrateGDPR requirements into company processes in partnership with Bureau Veritas, a world leader in its sector". And the lawyer added: "This framework will allow companies to attest their compliance with the new requirements arising from the Regulation and to enable them, in the face of this upheaval of their digital environment and the changing rules of the data game, to ensure that they have anticipated and implemented the essential measures necessary to be ready by May 2018".
About Bureau Veritas
Bureau Veritas is a world-leading provider in laboratory testing, inspection and certification. Created in 1828, the Group has more than 69,000 employees in around 1,400 offices and laboratories all across the world. Bureau Veritas helps its clients to improve their performance by offering services and innovative solutions in order to ensure that their assets, products, infrastructure and processes meet standards and regulations in terms of quality, health and safety, environmental protection and social responsibility.
Bureau Veritas is listed on Euronext Paris and belongs to the Next 20 index.
Compartment A, code ISIN FR 0006174348, stock symbol: BVI.
For more information, visit www.bureauveritas.com
Lexing is the first international network of lawyers dedicated to digital and technology law. Lexing® allows multinationals to benefit from the assistance of seasoned lawyers worldwide with established competence in the field of new technologies in their respective countries. Techniques and businesses are the same in all countries; the only differentiating factor is the law applicable to them. The Lexing® network now comprises some thirty law firms on all 5 continents.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13 | Pressemelding
Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21 | Pressemelding
Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38 | Pressemelding
A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00 | Pressemelding
Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a
AML BitCoin Enters Phase II of ICO15.12.2017 09:00 | Pressemelding
NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom